¥
6,481. 00
+26
+0.4028%
¥
590.23B Market Cap
- P/E Ratio
75% Div Yield
258,600 Volume
- Eps
¥ 6,455
Previous Close Want to track 3349 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cosmos Pharmaceutical Corp. (3349) Statistics
Valuation metrics
Market Cap 590.23B
Enterprise value 528.74B
Trailing P/E (ttm) 15.97
Forward P/E -
PEG ratio 4.63
Price/Sales (ttm) 0.47
Price/Book (mrq) 1.8
Enterprise Value/Revenue 0.48
Enterprise Value/EBITDA 7.71
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 411.8K
Average volume (90 days) 391.31K
Price summary
52-Week low 5,615
52-Week high 9,940
Beta -
50-Day moving average 6,341.17
200-Day moving average 6,490.98
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 82
Trailing annual dividend yield 0.0127%
5-Year annual dividend yield -
Payout ratio 0.19
Dividend Date 4 Aug 2026
Ex-Dividend Date 28 May 2026
Last split factor 2:1
Last split Date 29 Aug 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.03%
Operating margin 0.04%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 13,873.64
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 404.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 773.95
Total debt (mrq) -
Total Debt/Equity (mrq) 0.28
Current ratio (mrq) 0.77%
Book value per share (mrq) 3,579.53
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
